Fig. 2From: Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysisProgression free survival (a) and overall survival (b) in patients with cerebral relapse/progression (n = 54)Back to article page